Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Ann Oncol. 2012 Oct:23 Suppl 7:vii65-71. doi: 10.1093/annonc/mds227.

Authors

B Escudier¹, T Eisen, C Porta, J J Patard, V Khoo, F Algaba, P Mulders, V Kataja; ESMO Guidelines Working Group

Affiliation

¹ Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.

PMID: 22997456
DOI: 10.1093/annonc/mds227

No abstract available

Publication types

Practice Guideline
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Carcinoma, Renal Cell / diagnosis*
Carcinoma, Renal Cell / genetics
Carcinoma, Renal Cell / secondary
Carcinoma, Renal Cell / therapy
Combined Modality Therapy
Disease Management
Humans
Kidney Neoplasms / diagnosis*
Kidney Neoplasms / genetics
Kidney Neoplasms / pathology
Kidney Neoplasms / therapy
Molecular Targeted Therapy
Mutation
Neoplasm Staging
Prognosis
Risk Assessment
Treatment Outcome
Tumor Burden